Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Established Pharmacologic Class (EPC) Comparison, United States, 2024

ClinCalc.com » Pharmacy » ClinCalc DrugStats » Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Total Prescriptions in (2024)

Total Prescriptions by Drug Over Time

Drug Class Prescribing Trends Over Time

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2014-2024. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 2026.08. Read more about the ClinCalc DrugStats database.

All ClinCalc DrugStats figures and graphs on this page are licensed under Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0).